Clinical trial
Amlodipine Plus Botulinum Toxin for Focal Dystonia
NCT00015457 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00015457 |
|---|---|
| Title | Amlodipine Plus Botulinum Toxin for Focal Dystonia |
| Official title | Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Focal Dystonia |
| Intervention type | Drug |
| Interventions | Amlodipine plus Botulinum toxin |
| Enrollment | 16 |
| Start date | Apr 1, 2001 |
| Primary completion | Apr 1, 2009 |
| First posted | Apr 19, 2001 |
| Last update posted | Apr 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: